Published: 2017-06-24

Medical methods of abortion using lowest effective dose of mifepristone and misoprostol: case study of 100 women

Mehvish Anjum, Nivedita D.


Background: Medical abortion or Medical Methods of abortion (MMA) (or Chemical abortion) is defined as “the non-surgical way of termination of termination of pregnancy by a drug or combination of drugs”. With introduction of MMA there has been a steep rise in abortion related complications due to irrational use of these drugs. This study is undertaken using lowest effective dose of mifepristone and misoprostol in 100 women willing for termination of pregnancy with period of gestation <49 days to study the efficacy, side effects and failure rate. Present study emphasizes on using MMA by proper selection of patient, adhering to proper schedule under provision of MTP Act (counselling, consent, examination, confirmation of pregnancy, prescription by a registered medical practioner) in order to enhance efficacy and avoid complications.

Methods: Prospective Clinical Study consist of use of single dose of 200mg of mifepristone orally followed by misoprostol (400µg) by vaginal route for terminating pregnancy in ≤49 days of gestation. Statistical analysis done by Chi square test.

Results: In this study, success rate i.e. complete abortion without requiring surgical procedure was 96%and failure rate was 4%. Nausea (56%) is the most common side effect of Mifepristone. Chills (33%) is the most common side effect of Misoprostol. Mean Induction Abortion Interval is 2.17±1.2 hrs. Mean Duration of Bleeding is 7.79±4.42 days.

Conclusions: Medical abortion is a promising method of early abortion in a developing country like India as it requires no technical skills and manpower with a good safety profile.


Abortion, Bleeding, Mifepristone, Misoprostol

Full Text:



Comprehensive abortion care training and service delivery guideline. Ministry of Health and Family Welfare Government of India; 2010.

World Health Organization. Unsafe abortion: global and regional estimates of unsafe abortion and associated mortality in 2003. 5th edition. Geneva: World Health Organisation; 2007.

Creinin MD, AubÉny E. Medical abortion in early pregnancy. A clinician's guide to medical and surgical abortion. 1999:91-106.

Tang OS. Scheer H, Seyberth H, Lee SWH, Ho PC. Pharmacokinetics of different routes of administration of Misoprostol. Human Reproduction. 2002;17:332-6.

Goldberg AB, Greenberg MB and Danley PD. Misoprostol and pregnancy. N Eng J Med. 2001;344:38-47.

Breitbart V. Counselling in Medical Abortion. Am J Obstet Gynecol. 2000;183:26-33.

Crenin MD. Use of various ultrasonographic criteria, to evaluate efficacy of mifepristone and misoprostol for medical abortion. Am J Obstet Gynecol. 1999;181:1419-24.

Irving M, Bardin CW, Benton L, and Ann Robbins. Early Pregnancy Termination with Mifepristone and Misoprostol in United States. New Engl J Med. 1998;338(18):1241-6.

Ashok W. Penny GC. GMM Flett and Templet on. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. 1998;13:2962-65.

El Refaey H, Templeton A. Early induction of abortion by a combination of oral mifepristone and misoprostol adminintered by the vaginal route. Contraception. 1994;49:111-4.

Crenin MD, Courtney A. Mifepristone and Misoprostol Administered Simultaneously versus 24 hrs apart. Obstet Gynecol. 2007;109:885-94.

Shetty J. Medical Abortion by mifepristone with oral vs vaginal misoprostol. J Obstet Gynecol India. 2006;56(6):529-31.

Scaff EA, Eisinger SH, Stadaluis L, Franks P, Goreand BZ. Suzanne Poppema. Low dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. 1999;19:1-6.

Winikoff B, Sivin I, Coyaji KJ. The Efficacy of Medical abortion in China,Cuba and India: a comparative trial of mifepristone-mioprostol versus surgical abortion. Am J Obstet Gynecol. 1997;176:431-7.